February 18, 2025 –Melbourne, Australia – Mend Asia Pacific, market leaders in targeted peri-operative nutrition, is proud to announce the addition of Dr. Parker and Dr. Brett Fritsch to its esteemed team. This dynamic partnership marks an exciting step forward in Mend’s unwavering commitment to elevating the scientific and research capabilities that underpin its innovative nutrition solutions.
With Dr. Parker and Dr. Fritsch joining the team, Mend is poised to further strengthen its research foundations and drive the next wave of evidence-based advancements in peri-operative nutrition. Their extensive expertise in clinical research in the field of orthopaedics will be vital in advancing Mend’s cutting-edge approach, focused on helping us deliver tailored nutrition interventions that are designed to improve patient outcomes before, during, and after surgery.
“I am personally thrilled to welcome Dr. Parker and Dr. Fritsch into the Mend family,” said Goran Petrovic. I first met these two gentlemen over ten years ago while working for Medacta at an ACL Study Group meeting, an experience that shaped my perspective on professionalism in our field. Today, I feel privileged to work alongside them as we strive to elevate our research and push the boundaries of what is possible in perioperative nutrition. Their contributions will be crucial in ensuring that we continue to lead with the highest quality and integrity in everything we do.”
This partnership signifies Mend’s continued investment in research that shapes the future of patient care. By further enhancing its scientific capabilities, Mend is doubling down on its promise to deliver nutrition solutions backed by the strongest evidence available—solutions that make a meaningful difference in surgical recovery and patient health outcomes across Australia and beyond.
“Dr. Parker is an internationally renowned leader in knee surgery” says Dr. Robert Marx of Hospital for Special Surgery, “he is highly respected for his skill as a surgeon and also his clinical research. His vast knowledge and experience will contribute immensely to advancing Mend's science.”
Mend Asia Pacific’s commitment to pioneering advancements in targeted peri-operative nutrition remains as strong as ever, and with the addition of Dr. Parker and Dr. Fritsch, the company is primed to continue its leadership in developing innovative, scientifically backed solutions that improve patient recovery and optimize surgical outcomes.
“We’re truly honored to have Drs. Parker and Fritsch join our science team” says Mend CEO Eziah Syed, “they are both distinguished surgeons and highly regarded for their research and contributions to the advancement of the profession.”
For inquiries or further information on partnership or utilizing Mend’s solutions, please contact:
Goran Petrovic, CEO Mend AsiaPac
ausales@mend.me
Eziah Syed, CEO Mend
eziah@mend.me
About Mend
Mend is the leader in targeted perioperative nutrition and enhanced recovery, providing world-class, evidence-based solutions designed to optimise patient recovery and enhance surgical outcomes. With an unyielding focus on quality, research, and scientific integrity, Mend is at the forefront of driving advancements that help enhance recovery and outcomes. The company is headquartered in the USA with subsidiaries in Canada, Australia and Asia Pacific region.
